A novel approach to the treatment of benign prostatic hyperplasia.

about

Emerging drugs for the treatment of benign prostatic obstruction.

P2860

Q37743490-BF629528-89E3-41E3-93BE-A6DA58A21FF8

P2860

A novel approach to the treatment of benign prostatic hyperplasia.

Item

http://www.wikidata.org/entity/Q53255719

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

A novel approach to the treatment of benign prostatic hyperplasia.

@en

A novel approach to the treatment of benign prostatic hyperplasia.

@nl

type

Item

label

A novel approach to the treatment of benign prostatic hyperplasia.

@en

A novel approach to the treatment of benign prostatic hyperplasia.

@nl

prefLabel

A novel approach to the treatment of benign prostatic hyperplasia.

@en

A novel approach to the treatment of benign prostatic hyperplasia.

@nl

P1476

A novel approach to the treatment of benign prostatic hyperplasia

@en

P2093

Attila Varga

http://www.w3.org/2001/XMLSchema#string

György Walter

http://www.w3.org/2001/XMLSchema#string

Katalin Horváth

http://www.w3.org/2001/XMLSchema#string

P2860

Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.

Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.

Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction.

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

Medical therapy and quality of life.

The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail.

The concept of uroselectivity.

Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.

The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction.

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies.

P304

1252-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2006.06181.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Imre Romics

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16686721

http://www.w3.org/2001/XMLSchema#string

A novel approach to the treatment of benign prostatic hyperplasia.

about

P2860

P2860

A novel approach to the treatment of benign prostatic hyperplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698